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V I I I 
ABSTRACT 
IDENTIFICATION AND CHARACTERIZATION OF PHOTORHABDUS 
TEMPERATA MUTANTS ALTERED IN HEMOLYSIS AND VIRULENCE 
by 
Christine A. Chapman 
University of New Hampshire, December, 2011 
Photorhabdus temperata is an invertebrate pathogen and nematode symbiont that 
is commonly used as a biological control agent in the management of commercial crop 
pests. The focus of this study was to investigate the poorly understood molecular 
elements involved in the expression of hemolysis and virulence in this bacterium. A 
10,000 transposant library was screened using a blood agar plate assay to identify 
mutants altered in hemolytic activity. A total of 74 mutants displaying defective, delayed, 
or early hemolysis were identified and subsequently tested for altered virulence in the 
Greater Waxmoth, Galleria mellonella, using an in vitro mortality assay. Ten mutants 
delayed in pathogenesis were identified. Molecular analysis identified the sites of 
transposon insertion in 16 hemolysis mutants, eight of which also displayed delayed 
virulence. A critical finding of this study was the involvement of RNases in the 




ENTOMOPATHOGENIC NEMATODES AND AGRICULTURE 
In the United States alone, the agricultural industry spends $10 billion on 
pesticide use annually (Pimentel and Greiner, 1997) with a significant portion of this cost 
designated to the control of commercial crop insects. Still, 13% of all potential crops in 
the U.S. are destroyed due to insect damage (Pimentel, 1997). The necessity to control 
economically detrimental pests has resulted in the widespread use of potent chemical 
insecticides. Although historically effective, recent data highlight marked disadvantages 
as well as the decreasing efficacy of such chemicals. Concerns with chemical pesticide 
use include harm to nontarget organisms via contamination of soil and groundwater, 
biomagnification, and elimination of beneficial competitor insects (Chattopadhyay et al., 
2004). Veterinary use of broad spectrum pesticides risks contaminating products in the 
meat and dairy industries as well (Georgis et al., 2006). These chemicals tend to degrade 
slowly or not at all, resulting in environmental persistence and toxicity to humans 
(Chattopadhyay et al., 2004). Furthermore, the recent emergence of pesticide-resistant 
insects has necessitated the use of higher dosages and newly-developed chemicals. 
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Entomopathogenic nematodes have been in use as biological control agents in the 
United States since the 1980's (Georgis et al., 2006) and are growing in popularity in 
response to the call for reduced chemical pesticide use. Entomopathogenic nematodes are 
naturally soil-dwelling roundworms that infect larval-stage insects. The two genera of 
nematode used as biocontrol agents are Heterorhabditis and Steinernema, which form 
symbiotic relationships with the bacteria Photorhabdus and Xenorhabdus, respectively 
(Boemare et al., 1996). The exploitation of this natural symbiosis for pest control in 
agriculture offers numerous benefits over conventional chemical insecticide use. 
Entomopathogenic nematodes have a broad host range, capable of infecting over 200 
species of insects (Georgis et al., 2006), many of which are commercial crop pests. 
Additionally, the symbiotic bacterial species are a much safer alternative for animals and 
humans alike as they do not target vertebrate species (Boemare et a l , 1996). The risk for 
persistence and contamination is eliminated because nematodes do not accumulate in the 
environment. Because these species are actively predacious, they offer a high efficacy for 
insect control. The nematodes can be dispersed via traditional mechanisms used for 
pesticides, such as ground and aerial sprayers and irrigation systems (Chattopadhyay et 
al., 2004; Georgis, 1990), making the application of this type of biocontrol agent just as 
feasible as chemical insecticides. Finally, the use of organic biological control agent 
eliminates the risk of insects developing pesticide resistance. 
PHOTORHABDUS TEMPERATA AND RELATED SPECIES 
The genus Photorhabdus is comprised of three closely related but unique species, 
Photorhabdus temperata, Photorhabdus luminescens, and Photorhabdus asymbiotica, 
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which are further divided into subspecies based on phenotypic characteristics and 16S 
rDNA diversity (Fischer-Le Saux et al., 1999; Waterfield et al., 2009). All members of 
the Photorhabdus genus, however, are defined by several core characteristics. The 
Photorhabdus bacterium is a gram-negative, rod-shaped, facultatively-anaerobic, motile 
member of the Enterobacteriaceae and is the only known terrestrial bioluminescent 
bacterium (Gerrard et al., 2011; Waterfield et al., 2009). Photorhabdus lives in a 
mutualistic symbiotic relationship with heterorhabditid nematodes and is also pathogenic 
to insects (Waterfield et al., 2009). 
A peculiar aspect of the Photorhabdus life cycle is the transition from the typical 
wild-type form to a secondary form that exhibits a number of phenotypic changes. This 
rare phenotypic switch is referred to as phase variation and is believed to occur under 
conditions of prolonged laboratory cultivation (Akhurst, 1980). These two forms differ in 
their ability to absorb dyes on differential culture media including MacConkey, NBTA, 
and EMB agar. Additionally, the secondary variant has decreased or defective activity of 
extracellular enzymes, antimicrobial activity, and bioluminescence (Lanois et al., 2011). 
Photorhabdus is closely related to a sister species, Xenorhabdus. In 1993, Boemare et 
al. proposed the transfer of Photorhabdus to its own genus based on DNA relatedness. In 
2003, Duchaud et al. released the complete genome sequence of P. luminescens strain 
TT01. P. asymbiotica strain ATCC43949 has also been released (Wilkinson et al., 2009). 
P. asymbiotica is the clinical strain, which has been implicated in a few cases of human 
infection. The presence of a plasmid allows this species to grow at 37°C, while the others 
cannot (Wilkinson et al., 2009). Currently, the P. temperata NCI9 genome is being 
completed (Tisa, unpublished). 
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PHOTORHABDUS AND HETERORHABDITIS: PARTNERS IN CRIME 
P. temperata has a multiphasic life cycle requiring both pathogenesis of insects 
and a beneficial symbiosis with the nematode Heterorhabditis bacteriophora (Figure 1). 
Together, these mutualist entomopathogens infect a wide variety of insects where 
Photorhabdus assumes the role of a highly virulent pathogen. The pathogenic nature of 
Photorhabdus further supports the growth and development of Heterorhabditis within the 
insect host, thereby linking the two in a continuous cycle of symbiosis and pathogenesis. 
Heterorhabditis bacteriophora is a soil-dwelling entomopathogenic nematode 
which carries Photorhabdus within its intestine (Burnell and Stock, 2000). During its 
infective juvenile (IJ) stage, H. bacteriophora is free-living in the environment and is 
actively predacious against a variety of larval insects. The IJs infect suitable larval hosts 
via natural openings including the mouth, anus, and spiracles, or by penetrating the 
insect's cuticle directly. Once inside the insect's hemocoel, the nematodes regurgitate the 
bacterial cells which immediately begin working to break down the host's tissues (Ciche 
and Ensign, 2003). Although the nematodes themselves may inflict structural damage on 
the insect contributing to mortality, the action of potent exotoxins secreted by 
Photorhabdus ultimately destroys the insect (Burnell and Stock, 2000). 
Photorhabdus secretes a variety of toxins that kill the host in roughly 48 hours 
(Brillard et al., 2002; Burnell and Stock, 2000). Photorhabdus also releases exoenzymes, 
such as proteases, lipases, lipopolysaccharides, and cytolysins, within the hemocoel. The 
enzymes produced by the bacterial cells continue to degrade the internal environment of 
the insect, creating a milieu of nutrients in which the IJs mature into adult hermaphrodites 
and begin several generations of reproduction within the cadaver (Goodrich-Blair and 
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Clarke, 2007). This reproductive cycle lasts for two to three weeks before a new 
generation of IJs release a signal which triggers the uptake of Photorhabdus cells into the 
nematode intestine. The symbiotic pair then exits the cadaver and disperses into the 
environment where the IJs begin searching for new prey. 
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FIGURE 1. The life cycle of the Photorhabdus-Heterorhabditis association. A) 
Photorhabdus cells are carried symbiotically within the gut of the infective juvenile (IJ) 
stage of the nematode Heterorhabditis bacteriophora. B) IJs seek out and infect larval 
insect hosts in the soil. C) Once inside, Photorhabdus are released from the nematodes 
and kill the host within 48 hours and D) the IJs mature into adult hermaphroditic 
nematodes. E) The nematodes cycle through several generations of reproduction before 
taking the bacterial symbionts into their gut and exiting the cadaver. 
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VIRULENCE MECHANISMS 
Much like higher eukaryotic organisms, insects possess a myriad of molecular 
tactics for warding off infectious organisms. The insect immune system has two primary 
mechanisms of defense: humoral and cellular (Eleftherianos et al., 2010). Humoral 
immunity utilizes molecules involved in the detection and clearance of antigens, while 
the cellular mechanisms employ hemocytes involved in phagocytosis, foreign body 
encapsulation, and nodulation. Evasion of insect immune cells and antimicrobial peptides 
is crucial to the success of entomopathogens. 
The highly virulent nature of Photorhabdus is compounded by the numerous 
toxins employed by this bacterium. Several groups of virulence factors have been 
identified as the key players in insect pathogenesis: the toxin complexes (Tcs), the 
"makes caterpillars floppy" toxins (Mcf), the Photorhabdus insect related proteins (Pir), 
and the Photorhabdus virulence cassettes (PVC) (Rodou et al., 2010). 
The toxin complexes consist of four high molecular weight multisubunit 
complexes, Tea, Tcb, Tec, and Ted (Rodou et al., 2010). Toxin complex a (Tea) is the 
most abundant of these toxins and is highly lethal, exhibiting both oral and injectable 
activity (Blackburn et al., 1998; 2005). Tea works on the insect midgut, causing blebbing 
of the endothelium and eventual cell lysis (Blackburn et al, 1998), and is highly fatal on 
its own, possibly in concentrations as low as 1 part per million (Blackburn et al., 2005). 
RTX-like toxins have also been identified in Photorhabdus which resemble those found 
in Vibrio cholerae, Serratia marcescens, Erwinia tarda, and Erwinia chrysanthemi 
(Rodou et al., 2010). Among those are the metalloprotease PrtA, which may be involved 
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in immunosuppresion (ffrench-Constant et al., 2000; Duchaud et al., 2003) and host 
bioconversion (Bowen et al., 2003). 
There are two Mcf ("makes caterpillars floppy") toxins in Photorhabdus, Mcfl 
and Mcf2 (Rodou et al., 2010). These toxins contribute to insect death by inducing 
apoptosis of both epithelial and phagocytic cells within the midgut (Dowling et al., 2007). 
Infected insects display a characteristic floppy appearance due to this cellular breakdown 
which becomes apparent at roughly 12 h post-infection, preceding death. The presence of 
these toxins may help enable the bacteria in the infection of different insect species 
(Rodou et al., 2010). 
The Photorhabdus insect related (Pir) toxins, PirA and PirB, work together to 
confer injectable insecticidal activity (ffrench-Constant et al., 2007). PirB shares 
sequence similarities with p-leptinotarsin-h, a potent neurotoxin identified in the 
Colorado potato beetle hemolymph, as well as the pore-forming domain of Bt Cry toxins. 
These Pir toxins have the potential for use as biological control toxins, replacing the 
current Bt toxin from Bacillus thuringiensis, for which some insect resistance has 
emerged (Ahantarig et al., 2009). 
The most recently identified class of Photorhabdus toxins are the Photorhabdus 
virulence cassettes (PVCs) whose precise function has yet to be identified. These PVCs 
are encoded by multiple copies of genes exhibiting homology to toxin genes in Serratia 
entomophila specifically involved in antifeeding (Yang et al., 2006; Rodou et al., 2010). 
In Photorhabdus, these gene products have injectable activity that work on hemocytes to 
assist in insect killing; however, these products do not possess any antimicrobial activity 
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despite structurally resembling bacteriocins, specifically the R-type pyocins (Yang et al., 
2006). 
HEMOLYSIN ACTIVITY AND FUNCTION 
In addition to the diverse and potent toxins secreted by Photorhabdus, the primary 
phase wild type cells produce erythrocyte-lysing cytolysins, termed hemolysins (Brillard 
et al., 2001). Hemolysins are extracellular pore-forming or cell-hydrolyzing compounds 
secreted by many species of bacteria, and typically function as virulence factors in 
vertebrate pathogens (Brillard et al., 2001; Brillard et al., 2002). Although the precise 
function of hemolysins in Photorhabdus infectivity is unknown, evidence from other 
pathogenic systems may help elucidate their role. 
Serratia marcescens is both a vertebrate and invertebrate pathogen that expresses 
a two-partner hemolysin secretion system comprised of ShlA and ShlB (Brillard et al., 
2002; Hertle, 2005). In this system, ShlA is the hemolytic protein that is transported and 
activated by an outer membrane protein, ShlB. A similarly dependent two-partner 
secretion system has been identified in Photorhabdus luminescens, comprised of phlA 
and phlB, which contain sequence similarities with the S1. marcescens hemolysin loci shlA 
and shlB, respectively (Brillard et al., 2002). Similar products are found in P. temperata 
NCI9 as well (Tisa, unpublished). Additionally, the phlA and phlB amino acid sequences 
share homologies with hemolysin gene products of Edwardsiella tarda, Proteus 
mirabilis, and Haemophilus ducreyi, and a putative hemolysin of Yersinia pestis, YhlA 
(Brillard et al., 2002). 
Hemolytic activity is typically distinguished by the visual observation of clear 
halos on blood agar media, indicating erythrocyte lysis. Photorhabdus exhibits a distinct 
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pattern of hemolysis, termed "annular", first observed by Farmer et al. in 1989. Annular 
hemolysis is characterized by a thin line of hemolysis several millimeters away from the 
bacterial colony's edge, but no hemolysis immediately adjacent to the colony on sheep 
blood agar. This pattern, however, is not entirely unique; Bacillus cereus exhibits a 
similar "discontinuous hemolytic pattern", caused by the BL hemolysin (Beecher and 
Wong, 1994; Brillard et al., 2001). In addition, continued growth of both Photorhabdus 
and B. cereus leads to eventual lysis of erythrocytes within the annular ring. Interestingly, 
this BL hemolysin functions as a major virulence factor of B. cereus, causing 
dermonecrotic vascular permeability (Beecher and Wong, 1994). 
Numerous putative hemolysin genes have been identified in all three species of 
Photorhabdus. The complete genome sequence of P. luminescens TT01 reveals eight 
putative hemolysin- or hemagglutinin-related genes, including the phlBA operon 
(Duchaud et al., 2003). Eighteen putative hemolysin genes are present in the P. 
asymbiotica genome as well (Wilkinson et al., 2009). The currently unpublished draft 
genome sequence of P. temperata NCI9 contains 24 putative genes involved in 
hemolysis (Tisa, unpublished; http://rast.nmpdr.org/). 
Despite the evidence for numerous hemolysin genes in the Photorhabdus 
genomes, the identities and functions of these hemolytic compounds remain elusive. A 
study of the master flagellar operon flhDC in Xenorhabdus nematophilus suggested the 
presence of at least two types of hemolysin: oney7/zDC-independent hemolysin that gives 
rise to annular ring formation and one extracellular /7/zZ)C-dependent hemolysin 
potentially involved in cytotoxicity to insect immunocompetent cells (Givaudan and 
Lanois, 2000). Additionally, flhDC activity was shown to be involved in, but not required 
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for, insect infectivity. This finding indicates that there may be a large array of virulence 
factors involved in pathogenesis, but the loss of only a few of these factors may not be 
detrimental to pathogenesis. 
In 2001, Brillard et al. provide further evidence for the existence of two 
hemolysins in X. nematophila which are active at different stages of stationary phase and 
independently regulated (Brillard et al., 2001). These hemolysins also have different 
cytotoxicity against the two most prevalent types of insect immune cells, granulocytes 
and plasmatocytes. A hemolytic compound produced during early stationary phase is 
active against sheep erythrocytes and primarily toxic to granulocytes, the phagocytic 
immune cells. In contrast, late stationary phase cells produced a hemolysin active against 
rabbit erythrocytes and cytotoxic to plasmatocytes, the capsule-forming immune cells 
involved in the nodulation of foreign bodies. These two different cytolytic events imply a 
putative role of hemolysins in insect immunosuppression during infectivity with 
Xenorhabdus. 
A study of XhlA offered additional support for the involvement of hemolysins in 
Xenorhabdus virulence. Disruption of xhlA in X nematophila resulted in significantly 
attenuated virulence to Manduca sexta larvae, although this mutant ultimately remained 
lethal (Cowles and Goodrich-Blair, 2005). Further characterization of XhlA confirmed 
that this hemolysin is not responsible for the early cytolytic activity described by Brillard 
et al. (2001), as XhlA was primarily toxic to plasmatocytes. The absence of XhlA activity 
in culture supernatant also implies that this hemolysin remains cell-associated. Together, 
these data suggest that XhlA may function in virulence by assisting in immune system 
evasion or nutrient acquisition inside the insect. 
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Although early discoveries focused on hemolytic activity in Xenorhabdus, a study 
on the PhlA hemolysin provided evidence for at least two hemolysins in Photorhabdus as 
well (Brillard et al., 2002). An insertional mutation in phlA did not cause any alterations 
in hemolytic phenotype when compared to the parental wild type on both horse and sheep 
blood agar, indicating the presence of an additional hemolysin with activity on blood agar 
media. A liquid hemolysis assay, however, did detect the presence of PhlA hemolytic 
activity. Interestingly, this assay did not display any hemolytic activity when performed 
with filter-sterilized bacterial supernatant only. Similarly, no hemolytic activity was 
detected in Photorhabdus culture supernatant during the prior study on the effect of 
hemolysins on insect immunocompetent cells (Brillard et al., 2001). These studies 
suggest that coincubation of bacteria and erythrocytes is necessary to identify PhlA 
hemolytic activity, and that PhlA may actually be cytotoxic to insect immune cells as 
well (Brillard et al., 2002). 
Previous research on Photorhabdus and Xenorhabdus indicate a possible role of 
hemolysis in virulence; however, hemolysis may also function as an iron-scavenging 
mechanism during iron depletion. Primary phase P. luminescens displayed an increase in 
hemolytic activity under iron-depleted conditions compared to iron-supplemented 
conditions (Brillard et al., 2002), whereas the PhlA null mutant had no hemolysis in 
either condition. An injection assay using Spodoptera littoralis, however, showed that 
this PhlA mutant remained virulent, indicating that PhlA hemolytic activity is not a 
significant determinant of virulence in this organism. 
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RESEARCH AIMS AND SIGNIFICANCE 
Photorhabdus is a unique biological system because it is both an obligate 
symbiont of heterorhabditid nematodes and is highly pathogenic to insects. For this 
reason, Photorhabdus makes an excellent model organism for studying the molecular 
mechanisms involved in both pathogenesis and symbiosis and the relationship between 
these two stages of life. Another fascinating and unusual feature of this bacterium is its 
ability to lyse mammalian erythrocytes, a virulence factor typically associated with 
vertebrate pathogens (Brillard et al., 2001; Brillard et al., 2002). The absence of red blood 
cells in insects drives the central question of this research: What function, if any, do these 
hemolysins serve in the pathogenesis of this organism? Previous research, along with 
current knowledge of hemolysins in vertebrate pathogens, suggests a possible role in 
immunoevasion during insect infectivity (Brillard et al., 2001; Brillard et al., 2002; 
Cowles and Goodrich-Blair, 2005; Givaudan and Lanois, 2000). The main objectives of 
this study were to investigate the molecular mechanisms of hemolysin expression, to 
elucidate the role of hemolysins in Photorhabdus virulence, and to ultimately identify 
genes involved in pathogenesis. These objectives are outlined in Figure 2. 
Previously, a primary-phase Photorhabdus temperata NCI9 transposant library 
with 10,000 clones was constructed (Michaels, 2006) using a mini-Tn5 system previously 
described (Ciche et al., 2001). The first aim of this study was to screen this library via a 
blood agar plate assay to identify mutants displaying altered hemolytic phenotypes. The 
goal of identifying these mutants was to characterize them on the molecular level in order 
to understand the genetic elements involved in the expression, regulation, and transport 
mechanisms of hemolysins in Photorhabdus. 
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The second major focus of this research was to investigate the genes involved in 
insect pathogenesis. An in vitro injection assay developed by Clarke and Dowds (1995) 
uses Galleria mellonella larvae to study Photorhabdus virulence. Although this 
procedure is too labor intensive to perform on the entire transposant library, it is effective 
for studying pathogenesis in a smaller group of mutants. Initial screening for hemolysis 
allowed for the pathogenic characterization of a subset of the library. Previously, an 
investigation of Photorhabdus motility mutants found that the absence of RNase II 
activity resulted in attenuated virulence (Rowedder, 2009). This finding offered the first 
evidence of RNase involvement in the regulation of pathogenesis. Virulence assays in 
this study served two purposes: first, to identify mutants altered in pathogenesis for 
further molecular characterization, and second, to investigate the potential role between 
hemolytic activity and pathogenesis. Ultimately, the mutants altered in both hemolysis 
and virulence identified in this study were the main focus for further genetic and 
physiological characterization. 
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Identify mutants altered in 
hemolytic activity from a mutant 
library with 10,000 clones 
r 
Use identified hemolysis mutants 
for further physiological and 
molecular characterization. 
Identify genes involved in the 
synthesis, regulation, and 
transport of hemolysins in P. 
temperata. 
] 
Identify mutants altered in 
pathogenesis from the hemolysis 
mutants 
Identify genes involved in the 
regulation of pathogenesis and 
hemolysis 
Determine role of hemolysins in 
insect pathogenesis 
FIGURE 2. Experimental design for the study of hemolysis and virulence in P. temperata. 
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CHAPTER II 
MATERIALS AND METHODS 
BACTERIAL STRAINS AND GROWTH CONDITIONS 
Photorhabdus temperata strain NCI9 (ATCC 29304) was used as the parental 
wild type bacterium in all experiments throughout this study. Table 1 lists all of the 
strains and plasmids used in this study. Both primary (1°) and secondary (2°) phase 
phenotypic variants were used as controls in this study. Parental wild type cultures were 
grown in Luria-Bertani (LB) medium [1% Bacto-Tryptone (Difco Laboratories, Sparks, 
MD), 0.5% yeast extract, 0.5% NaCl], and mutant cultures were grown in LB 
supplemented with kanamycin [25 u.g/ml]. 
A primary phase P. temperata NC19 mutant library was previously generated via 
transposon mutagenesis with the mini-Tn5 vector pUB394 (Michaels, 2006). Mutants 
from this library were used throughout this study. 
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Table 1. Bacterial strains and plasmids used in this study 










































General cloning strain 
General cloning strain 
Indicator strain 
Primary parental wild type 
Secondary variant parental wild type 
Early hemolysis; KanR 
Defective hemolysis; KanR 
Defective hemolysis; KanR 
Defective hemolysis; KanR 
Defective hemolysis; KanR 
Defective hemolysis; KanR 
Defective hemolysis; KanR 
Defective hemolysis; KanR 
Early hemolysis; KanR 
Defective hemolysis; KanR 
Delayed hemolysis; KanR 
Delayed hemolysis; KanR 
Early hemolysis; KanR 
Delayed hemolysis; KanR 
Delayed hemolysis; KanR 
Delayed hemolysis; KanR 
Early hemolysis; KanR 
Delayed hemolysis; KanR 
Delayed hemolysis; KanR 
Defective hemolysis; KanR 
Early hemolysis; KanR 
Delayed hemolysis; KanR 
Defective hemolysis; KanR 
Delayed hemolysis; KanR 
Delayed hemolysis; KanR 
Early hemolysis; KanR 
Defective hemolysis; KanR 
Defective hemolysis; KanR 
Early hemolysis; KanR 
Defective hemolysis; KanR 
Delayed hemolysis; KanR 









































Table 1 (cont.) 










































Defective hemolysis; KanR 
Delayed hemolysis; KanR 
Defective hemolysis; KanR 
Defective hemolysis; KanR 
Defective hemolysis; KanR 
Defective hemolysis; KanR 
Defective hemolysis; KanR 
Defective hemolysis; KanR 
Delayed hemolysis; KanR 
Early hemolysis; KanR 
Defective hemolysis; KanR 
Early hemolysis; KanR 
Delayed hemolysis; KanR 
Defective hemolysis; KanR 
Defective hemolysis; KanR 
Delayed hemolysis; KanR 
Delayed hemolysis; KanR 
Defective hemolysis; KanR 
Delayed hemolysis; KanR 
Defective hemolysis; KanR 
Defective hemolysis; KanR 
Delayed hemolysis; KanR 
Defective hemolysis; KanR 
Defective hemolysis; KanR 
Defective hemolysis; KanR 
Defective hemolysis; KanR 
Defective hemolysis; KanR 
Defective hemolysis; KanR 
Defective hemolysis; KanR 
Defective hemolysis; KanR 
Defective hemolysis; KanR 
Defective hemolysis; KanR 
Early hemolysis; KanR 
Defective hemolysis; KanR 
Defective hemolysis; KanR 
Defective hemolysis; KanR 
Defective hemolysis; KanR 
Early hemolysis; KanR 
Delayed hemolysis; KanR 












































Table 1 (cont.) 
Source or 
Strain or Plasmid Function/Characteristics Reference 
90 B9 Defective hemolysis; KanK Michaels, 2006 
90 E2 Defective hemolysis; KanR Michaels, 2006 
Plasmids 
pUB384 mini-Tn5 delivery vector; KanR, StrR, SpecR Ciche et al., 2001 
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HEMOLYSIS ASSAY TO IDENTIFY MUTANTS ALTERED IN HEMOLYTIC ABILITY 
The transposon mutant library was screened for hemolysis activity on blood agar 
plates (Figure 3). Blood agar medium was composed of T-soy [3% Tryptic Soy Broth 
(EM Science, Darmstadt, Germany), 2% Bacto-Agar (Difco Laboratories)] supplemented 
with sheep's blood [5%, v:v]. For the screening experiments, blood agar medium was 
poured into oversized petri dishes (150x15 mm; Fisher Scientific, Canada). The mutant 
library was stored at -80°C in a collection of 96-well microtiter plates as previously 
described (Michaels, 2006). Using a 96-well replicator, the -80°C stored transposants 
were transferred into 96-well microtiter plates containing fresh LB medium with 
kanamycin and incubated overnight at 28°C. The freshly grown overnight culture was 
replica plated directly onto the oversized blood agar plates. Two ul of the primary and 
secondary phase parental wild type cells were spotted on each plate as controls. Plates 
were incubated at 28°C and observed at 24, 48, and 72 h for hemolytic patterns. Criteria 
for determining altered hemolytic activity were time-dependent. Putative mutants 
displayed early, delayed, or defective hemolysis when compared to the primary parental 
wild type which exhibited hemolysis between 19 and 24 h. Preliminary mutants identified 
as altered in their hemolytic pattern were purified by isolation streaks and retested at least 
3 times. For these cultures, 2 ul of each overnight broth culture including the primary and 
secondary wild type controls were spot inoculated onto the surface of blood agar plates 
and incubated for 72 h. Hemolytic activity was monitored every 24 h. Confirmed mutants 
were purified by streaking on LB agar containing kanamycin. A single colony was 
inoculated into LB broth and grown overnight. Cells were suspended in 30% glycerol and 













X v X Defective 
r!v<^ Early' 
1° ~J~~ 2° 
FIGURE 3. Hemolysis plate assay for the screening and identification of hemolytic 
mutants. A) Overnight grown cultures in 96-well plates were spot inoculated onto sheep 
blood agar plates by the use of a pin replicator and incubated at 28°C. B) Hemolytic 
activity was observed at 24, 48, and 72 h post-incubation. C) Putative hemolytic mutants 
were subcultured and 2 ul of each overnight culture was spot inoculated onto blood agar 
plates for verification. 
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IN VITRO INSECT PATHOGENESIS ASSAY 
Insect pathogenesis was assessed by a modified method of Clarke and Dowds 
(1995) and used the greater wax moth larvae, Galleria mellonella, (Grubco, Inc. 
Hamilton, OH) as the host (Figure 4). Prior to use larvae were stored at room temperature 
in wood shavings for up to two weeks. Bacterial cultures were grown in LB broth 
overnight at 28°C with agitation and optical density of the culture was measured with a 
Shimadzu UV-2401 PC spectrophotometer (Norwell, MA). Cultures were diluted to an 
OD60o of 1-0 and subsequently serially diluted. Ten ul of the 10"5 dilution (approximately 
100 cells) were injected directly into the hemocoel of 20 larvae. Controls consisted of 
primary and secondary parental wild type cells and sterile LB medium (no cells; negative 
control). Insect mortality was monitored regularly for 60 h and the lethal time required to 
kill half of the larvae (LT50) and all of the larvae (LTioo) was determined. Mutants 
displaying LT50 or LT100 that differed by greater than 10 h from the parental wild type 
values were considered to have an enhanced (<10 h) or delayed (>10 h) pathogenesis 
response. To obtain a viable cell count for each inoculum, 10 ul of the injected dilution 
was spread plated onto LB agar containing 10% pyruvate (supplemented with kanamycin 
for mutant cultures) and incubated at 28°C overnight. A multiplicity of infection (MOI) 
assay was used to confirm that the altered virulence observed in putative pathogenesis 
mutants was not dose-dependent. This assay tested cultures at four dilutions and was 
performed as previously described, using 10 |j.l culture from the 10"2 through 10"5 
dilutions. These dilutions corresponded to infective doses ranging from 10,000 to 10 
cells, respectively. As before, insect health was monitored for 60 h and compared to the 








FIGURE 4. iw vitro insect pathogenesis assay. A) Overnight cultures were standardized to 
an OD6oo of 1.0 and serially diluted 10-fold. B) Viable counts were obtained by spread 
plating 10 u.1 of each dilution onto LB agar containing pyruvate. C) For each Galleria 
mellonella larva, 10 JJ.1 of the appropriate dilution was injected into the hemocoel and 20 
larvae in total were injected for each sample. D) Insect mortality was monitored over a 60 
h time period. 
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PHYSIOLOGICAL ASSAYS 
Phenotypic properties of the mutants were determined by the use of standard plate 
assays for virulence factors and dye binding as described previously (Hodgson et al., 
2003). 
DYE BINDING 
Bacteria were streaked onto the following four growth media containing dyes: (1) 
MacConkey agar (Difco Laboratories), (2) EMB [2% Proteose Peptone 3 (Remel, 
Lenexa, KS), 2% Bacto-Agar, 0.04% Eosin Y, 0.0067% Methylene Blue], (3) NBTA 
[2.3% Nutrient Agar (Difco Laboratories), 0.0025% Bromothymol Blue, 0.004% 
triphenyl-tetrazolium chloride (TTC)] and (4) LB agar containing calcofluor dye (0.02 
mg/mi). For Photorhabdus, the first three indicator media are primarily used to determine 
phase variation (Boemare et al., 1997; Hodgson et al., 2003). Inoculated media were 
incubated at 28°C for 72 h. Primary phase parental wild type cells form red colonies on 
MacConkey, while secondary phase colonies appear light orange or pink. On EMB 
medium, primary phase colonies appear shiny metallic green, while secondary phase 
colonies are opaque purple. Primary phase colonies on NBTA medium display a dark 
green color, while secondary phase colonies are lighter green and pink. Secondary phase 
colonies will bind the fluorescent dye, calcofluor, and will fluoresce under UV light. The 
primary phase cultures do not bind the calcofluor dye and do not fluoresce under UV 
light. 
PROTEASE ASSAYS 
Besides dye binding, mutants were screened for altered phenotypes involving 
secreted products. To assess protease activity, 2 ul of overnight culture was spotted onto 
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gelatin plates [2.3% Nutrient Agar (Difco Laboratories), 1.2% gelatin (Difco 
Laboratories)] and the radii of clearing zones were measured in mm at 24 and 48 h and 
compared to the zones of the primary and secondary parental wild types. At 48 h, a halo 
greater than 2 mm was designated positive (+), a halo with a radius of less than 2 mm 
was designated intermediate (+/-), and the absence of any clearing zone was noted as 
negative (-). 
LIPASE ASSAYS 
Primary phase Photorhabdus secretes lipase extracellularly. To test for lipase 
production in mutants, 2 ul of overnight culture was spotted onto Spirit Blue agar [3.5% 
Spirit Blue Agar (Difco Laboratories), 3% (v:v) Bacto-Lipase Reagent (Difco 
Laboratories)]. Primary phase parental wild type exhibits a halo around the colony after 
48 h incubation at 28°C, while the secondary phase wild type does not. Mutant cultures 
displaying a halo with radius greater than 1 mm were noted as positive (+) while the 
absence of a halo was designated negative (-). 
DNASE ASSAYS 
DNase activity of pathogenesis mutants was assessed by spot-inoculating 2 ul 
overnight culture onto DNase plates containing methyl green (Difco Laboratories) and 
incubated at 28°C. The primary parental wild type produces a 2 mm halo of clearing at 48 
h, indicating DNA degradation, while the secondary wild type produces a 1 mm zone. 




Antimicrobial activity was assessed by the agar plug method. Cultures were 
grown to confluency on Proteose Peptone 3 agar [2% Proteose Peptone 3 (Remel), 2% 
Bacto-Agar, 0.5% NaCl] for 72 h at 28°C and 5-mm-diameter plugs were extracted. The 
plugs were placed onto the surface of LB plates inoculated with an overnight culture of 
Micrococcus luteus. Plates were incubated overnight at 37°C and zones of inhibition 
were recorded in mm (radius). 
SIDEROPHORE ASSAYS 
To assess siderophore production in hemolysis mutants, 2 ul of an overnight 
culture was spot-inoculated onto Chrome Azurol S agar (CAS) (Schwyn and Neilands, 
1987) and incubated at 28°C. The radii of resulting halos were measured in mm. An 
orange halo greater than 2 mm surrounding the colonies after 48 h incubation indicated 
positive siderophore production (+), a radius of less than 2 mm was designated 
intermediate production (+/-), and the absence of a halo denoted negative siderophore 
production (-). 
MOTILITY ASSAYS 
Motility in the form of swimming and swarming was assessed for all hemolysis 
mutants. Swimming motility (movement through liquid) was assayed as previously 
described (Hodgson, 2003). Briefly, overnight culture was stab-inoculated into the center 
of swim medium [1% peptone (Difco Laboratories), 1% yeast extract, 0.5% NaCl, 0.25% 
Bacto-Agar] and the diameter of swim rings were measured (mm) after 24 and 48 h 
incubation at 28°C. Swarming motility (surface movement) was assayed as previously 
described (Michaels and Tisa, 2011). Briefly, 2 ul overnight liquid culture was spot-
inoculated onto the surface of PP3-swarm medium [2% Proteose Peptone 3, 0.5% yeast 
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extract, 0.5% NaCl, 0.65% Bacto-agar] and the diameter of swarm rings was measured 
(mm) after 24 and 48 h incubation at 28°C. 
GROWTH ASSAYS 
Cultures were grown overnight in LB broth and subsequently diluted to OD595 of 
0.1 in fresh LB medium without kanamycin. Diluted cultures (200 ul) were inoculated 
into sterile 96-well polystyrene microtiter plates. The inoculated plates were placed into a 
Tecan plate reader with Magellan software (Tecan Group Ltd., Switzerland) and 
incubated at 28°C with shaking. The OD595 was measured every half hour for a 24-h 
period. The average and standard deviation of each sample was determined from the 
replicate wells (n=6) and these values were plotted versus time. The doubling times were 
determined for the mutants and the primary and secondary parental wild types. 
QUANTITATIVE HEMOLYSIS ASSAY 
Confirmed virulence mutants were further assayed for hemolytic activity using a 
quantitative liquid hemolysis assay modified from Hertle et al. (1999), and from 
Ondraczek et al. (1992). For each mutant, a 48-h liquid culture was assessed for 
hemolytic activity with (1) filter-sterilized culture supernatant, (2) bacterial cells washed 
with PBS [137 mM NaCl, 2.7 mM KC1, 10 mM phosphate buffer, pH 7.3-7.5 (EM 
Science)], and (3) whole-culture suspension in LB broth. Primary and secondary parental 
wild type cultures were used for comparative purposes, while 10% sodium dodecyl 
sulfate (SDS) served as a positive control and LB as a negative control. For each sample 
and controls, 100 ul sample was added to 1 mL washed 10% sheep erythrocytes in PBS 
and incubated with agitation at 28°C for 4 h. Absorbance (A405) was measured every hour 
and hemolytic activity was calculated using the formula [(A405 Sample - A405 Negative 
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control)/A405 Positive control] X 100 = Hemolytic Units. Hemolytic units were plotted 
versus time to assess the hemolytic activity of each sample for each mutant compared to 
the primary and secondary parental wild types. 
MOLECULAR CHARACTERIZATION 
Genomic DNA (gDNA) was extracted by the cetyltrimethylammonium bromide 
(CTAB) method (Murray and Thompson, 1980) and DNA yield and purity were 
determined using the NanoDrop 2000c spectrophotometer (Thermo Scientific, 
Wilmington, DE). 
The transposon and flanking DNA regions were recovered using a rescue cloning 
protocol (Ciche et al., 2001). Ten ug genomic DNA was digested overnight with 10 U 
Nsil (New England BioLabs Inc., Ipswich, MA) and subsequently self-ligated using 10 U 
T4 DNA ligase (New England BioLabs Inc.) and 50 ul T4 DNA Ligase Reaction Buffer 
(10X) in a 500 ul reaction at room temperature overnight. Ligated plasmids were 
electroporated into E. coli DH5a using an E. coli Pulser (Bio-Rad Laboratories, Hercules, 
CA). Electrocompetent DH5a were prepared by subculturing overnight culture in LB 
broth, growing to OD600 0.5-0.7, and performing three washes with ice-cold 1 mM 
HEPES {2-[4-(2-Hydroxyethyl)-l-piperazine]ethanesulfonic acid, Acros Organics, New 
Jersey} at 4°C before storing cells in 10% glycerol at -80°C. After electroporation, 
transformed cells were recovered in SOC medium (2% tryptone, 0.5% yeast extract, 
0.058% NaCl, 0.019% KC1, 0.2% MgCl2-6H20, 0.49% MgS04-7H20, 0.36% glucose) 
for 2 h at 37°C before plating on LB agar supplemented with kanamycin. Plates were 
grown overnight at 37°C and resulting colonies were analyzed for the presence of 
plasmid. 
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Recovered plasmids were isolated by the use of the QIAprep® Spin Miniprep Kit 
(Qiagen Inc., Valencia, CA) according to manufacturer's instructions. Genetic material 
flanking the transposon was sequenced using primer M13R-27 (Table 2) and performed 
at the Hubbard Center for Genome Studies at the University of New Hampshire (Durham, 
NH). Sequence was analyzed using the P. temperata genome available on RAST 
[http://rast.nmpdr.org, (Aziz et al., 2008)] and P. luminescens and P. asymbiotica 
genomes available on NCBI's BLAST program (http://blast.ncbi.nlm.nih.gov/Blast.cgi). 
RESTRICTION FRAGMENT LENGTH POLYMORPHISM 
Mutants of interest displaying markedly unusual characteristics were analyzed to 
confirm that they were Photorhabdus cultures and not contaminating organisms. 
Polymerase chain reaction (PCR) of the 16S gene region was performed on mutant and 
primary parental wild type gDNA (~150 ng) using primers 27F and 1492R (10 uM) 
(Table 2). Thermal cycling parameters included initial denaturation at 94°C for 2 min, 
followed by 35 cycles of denaturation for 30 sec (94°C), primer annealing for 30 sec 
(54°C), and extension for 90 sec (68°C), followed by a final elongation for 5 min at 68°C. 
PCR product was purified using the QIAquick® PCR Purification Kit (Qiagen Inc.) and 
digested with 10 U Haelll (New England BioLabs Inc.) according to manufacturer's 
instructions. Digested DNA was electrophoresed on 2% agarose in IX TAE (40 mM 
Tris-acetate, lmM EDTA, pH 8.1-8.5). Fragment sizes of each mutant were compared to 
the primary parental wild type. 
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Table 2. Primers used in this study 
Primer Primer set (5'-3') Gene Reference 
27F 
1492R 
HCP Set 5 





Pte3807 Set 5 
Pte3807 Set 5 
Pte3808 Set 3 













AGA GTT TGA TCA TGG CTC AG 
ACG GCT ACC TTG TTA CGA CTT 
CTT AAG CCA CGC GAT AAC ATG AGC 
CCT GCG ATA AGG TGA TTC CAG GTA 
GTA AAA CGA CGG CCA GTG 
GGA AAC AGC TAT GAC CAT G 
GTA AAC TGG ATG GCT TTC TTG CCG 
ATA TCA CGG GTA GCC AAC GCT ATC 
ATT CGC CAG CTT ACA GGA TGC CTA 
TCG CTG ATA GGC ATG TAA GGC AGT 
CGT TAT GGG CAA CAT TCC TGG CAA 
CTT TCA TCA CGC GCC GGT AAA CAT 
Universal 16S rRNA 











Weisburg et al., 1991 











CONFIRMATION OF TRANSPOSON INSERTION SITES 
To confirm the location of transposon insertion in the genome, a PCR approach 
was used. Primers (10 uM) designed for reverse transcription PCR (Table 2) were used to 
amplify genes of interest from approximately 100 ng mutant and wild type gDNA. DNA 
regions containing the inserted transposon yielded products approximately 2.5 kb larger 
than the expected product size when compared to the primary parental wild type 
products. Cycling parameters included an initial denaturation at 94°C for 5 min, followed 
by 35 cycles of denaturation for 30 sec (94°C), primer annealing for 30 sec (58°C), and 
extension for 3.5 min (72°C), followed by a final elongation for 10 min at 72°C. 
Amplified product was subjected to electrophoresis in a 2% agarose matrix in IX TAE 
buffer and visualized by ethidium bromide staining. 
RNA EXTRACTION 
RNA was extracted from mutants of interest and parental wild type cultures. 
Overnight cultures were subcultured in fresh LB and grown to OD600 ~0.7 before 
harvesting 500 ul using the Qiagen RNAprotect™ Bacteria Reagent and Qiagen 
RNeasy® Protect Bacteria Mini Kit according to manufacturer's instructions (Qiagen 
Inc.). RNA was eluted from the spin column membrane using 50 ul RNase-free water. 
For purification of RNA samples, IX DNase I Reaction Buffer (New England BioLabs 
Inc.), 5 U DNase I (New England BioLabs Inc.), 200 U RNaseOUT™ Recombinant 
Ribonuclease Inhibitor (Invitrogen Corporation, Carlsbad, CA), and DEPC-treated water 
were added to the 50 ul RNA samples to a final volume of 100 ul Samples were 
incubated for 30 min at 37°C before inactivation of the DNase I with 1 ul 0.5 M EDTA, 
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pH 8.0 (Ambion Inc., Austin, TX), at 75°C for 10 min. RNA yield and purity was 
determined using the NanoDrop 2000c spectrophotometer (Thermo Scientific). 
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION (RT-PCR) 
Reverse transcription of mRNA and subsequent cDNA amplification determined 
the effect of transposon insertion on transcription for genes of interest. The GoScript™ 
Reverse Transcription System was used for cDNA first-strand synthesis according to 
manufacturer's instructions (Promega Corporation, Madison, WI). RNA (300 ng) and 
random primers (0.5 ug) were denatured at 70°C for 5 min before the addition of 1 ul 
GoScript™ Reverse Transcriptase, 4 ul GoScript™ 5X Reaction Buffer, MgCl2, 0.5 mM 
dNTPs, and nuclease-free water to a final volume of 20 ul. The primers were annealed at 
25°C for 5 min and extended at 42°C for 60 min. cDNA was stored at -20°C until 
amplification. 
Amplification was performed on 500 ng cDNA using 10 uM forward and reverse 
gene-specific primers (Table 2). Thermal cycling parameters included initial denaturation 
at 94°C for 5 min followed by 35 cycles of denaturation for 30 sec (94°C), primer 
annealing for 30 sec (58°C), and extension for 2.5 min (72°C) with a final elongation at 
72°C for 7 min. Amplified product was subjected to electrophoresis in a 2% agarose 
matrix in IX TAE buffer and visualized by ethidium bromide staining. 
SOUTHERN HYBRIDIZATION 
Southern hybridization was used to ensure that the phenotypes observed in the 
pathogenesis mutants were caused by a single insertion of the transposon into the 
genome. For this study, a probe was designed to detect the kanamycin resistance gene of 
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the transposon. The kanamycin gene was amplified from 100 ng of the delivery vector, 
pUB394, using the PT-KAN primer set (10 uM) (Table 2). PCR product was purified 
using the QIAquick® PCR Purification Kit (Qiagen Inc.) according to manufacturer's 
instructions and quantified. The Amersham Gene Images AlkPhos Direct Labelling and 
Detection System (GE Healthcare, Buckinghamshire, UK) was used to label 200 ng Kan 
product according to manufacturer's instructions. The labeled probe was kept on ice for 
up to 2 h before use. 
For Southern hybridization, 5 ug mutant and primary wild type gDNA were 
digested overnight with 5 U Nsil (New England BioLabs Inc.) at 37°C. As a positive 
control, 50 ng pUB394 was used. The plasmid was linearized by digesting overnight with 
10 U Sacl (New England BioLabs Inc.) at 37°C. Digests were separated in 0.8% agarose 
in IX TAE at 6 V/cm and visualized with ethidium bromide. The gel was soaked in 0.25 
N HCl for 15 min with gentle agitation to depurinate the DNA, then rinsed with distilled 
water. DNA was denatured by soaking the gel in 0.5 M NaOH and 1.5 M NaCl for 30 
min with gentle agitation. After rinsing with distilled water, the gel was neutralized for 30 
min in 0.5 M Tris-Cl, pH 7.0, 3 M NaCl with gentle agitation and equilibrated in 20X 
SSC (3 M NaCl, 0.3 M sodium citrate, pH 7.0) for 5 min. A positively-charged nylon 
membrane (Amersham Pharmacia Biotech) cut slightly larger than the gel was wetted for 
1 min in distilled water and soaked in 20X SSC for 5 min. The equilibrated gel and 
membrane were assembled in a reservoir transfer system and the DNA was transferred 
overnight using 20X SSC. After transfer, the membrane was washed in 2X SSC for 2 min 
and the DNA was fixed to the membrane by baking for 2 h at 80°C between two pieces 
of filter paper in a glass dish. 
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Prehybridization (15 min) and hybridization (overnight) of the membrane were 
performed at 65°C using AlkPhos Direct hybridization buffer (GE Healthcare) containing 
0.5 M NaCl and 4% (w:v) blocking reagent with 200 ng Kan probe according to 
manufacturer's instructions. Post-hybridization stringency washes were performed at 
65°C with primary wash buffer [2 M urea, 0.1% (w:v) SDS, 50 mM Na phosphate, pH 
7.0, 150 mM NaCl, 1 mM MgCl2, 0.2% (w:v) blocking reagent] twice, for 10 min each, 
followed by two 5-min washes at room temperature with secondary wash buffer (50 mM 
Tris base, 100 mM NaCl, 2 mM MgCl2). The membrane was incubated with 40 uVcm2 
CDP-Star™ chemiluminescent detection reagent for 5 min before wrapping in plastic 




IDENTIFICATION OF HEMOLYSIS MUTANTS 
A previously constructed transposon library consisting of approximately 10,000 
primary phase P. temperata mutants (Michaels, 2006) was screened for mutants altered in 
hemolytic activity. The time of hemolysis initiation for each mutant was observed, and 
mutants displaying markedly different activity from the primary parental wild type were 
recorded. Primary phase cells displayed annular hemolysis activity between 19 and 24 h 
incubation at 28°C, while secondary phase cells showed no hemolytic activity even with 
prolonged incubation (72 h). Since individual mutants with elevated or decreased levels 
of hemolysis activity were not apparent from this screening protocol, the time required 
for the initiation of hemolysis was used as a criterion for mutant identification. Initial 
screening identified mutants in two categories: 756 putative early hemolysis mutants and 
1,279 putative defective hemolysis mutants. Putative early mutants had clearing zones 
visibly larger than the primary parental wild type by 24 h, and putative defective mutants 
lacked any halo at 48 h. These hemolysis mutants were subsequently confirmed four 
additional times by spotting 2 ul of overnight liquid culture onto blood agar plates. 
During this confirmation procedure, a third category, delayed hemolysis, was identified 
from the mutants originally thought to be defective. The delayed mutants were separated 
based on the initiation of hemolysis between 48 and 72 h, whereas the defective mutants 
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had no hemolysis after 72 h. A total of 74 mutants were confirmed and classified as 
belonging to one of the three different categories of hemolysin mutant: Defective activity, 
Delayed activity, and Early activity (Table 3). Forty-four mutants were grouped into the 
defective for hemolysis category and showed no hemolytic activity after 72 h incubation. 
Nineteen mutants exhibited a delayed hemolysis phenotype, which was characterized by 
initiation of hemolysis activity between 48 and 72 h incubation (approximately 24 h later 
than the wild type activity). Eleven mutants had an early hemolysis phenotype, which 
displayed hemolysis activity after 14-17 h incubation (approximately 10 h earlier than the 
wild type). Confirmed hemolysis mutants were subsequently screened for alterations in 
other phenotypes. 
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Table 3. Hemolysis screening results: Mutant hemolytic categories 
Hemolysis Mutants Identified Description 
Defective 44 No hemolysis activity after 72 h 
Delayed 19 Initiation of hemolysis between 48 and 72 h 
Early 11 Initiation of hemolysis before 17 h 
Primary wild type Positive control Initiation of hemolysis between 19 and 24 h 
Secondary wild type Negative control No hemolysis activity after 72 h 
PHYSIOLOGICAL CHARACTERIZATION OF THE HEMOLYSIS MUTANTS 
A variety of physiological traits were assessed for the 74 hemolysis mutants and 
compared to the primary and secondary parental wild types (Table 4). Dye binding and 
pigmentation were used to assess the phenotypic phase of each mutant to ensure that 
altered hemolytic activity was not attributed to phase variation. Extracellularly-secreted 
products including protease, lipase, siderophore, and antimicrobials were evaluated. 
These are all potential virulence factors and are used to distinguish the primary and 
secondary phenotypic variants as well. Lastly, swimming and swarming behavior were 
measured for each mutant to identify altered motility. 
The majority of the hemolysis mutants had all or most of their phenotypes 
resemble those of the primary parental wild type. The most physiological variation was 
observed in the defective hemolysis group; 19 of the 44 mutants had strictly primary 
characteristics, while 17 mutants displayed a mix of predominantly primary traits with 
some secondary characteristics. Within this group were 5 mutants defective for protease, 
one mutant defective for lipase, one mutant defective in both lipase and protease, 3 
mutants defective in swarming motility, 3 mutants defective in swimming motility, one 
mutant defective in both swimming and swarming, two lacking colony pigmentation, and 
one defective in dye binding, lipase, antibiotic production, swimming, and swarming. 
Only 8 defective hemolysis mutants displayed primarily secondary characteristics; 
however, none of these mutants had phenotypes that were entirely secondary. These data 
indicate that all mutants were primary variants, but that the transposon insertion often 
disrupted phenotypes other than hemolysis. All 19 delayed hemolysis mutants displayed 
mostly primary phenotypes, only resembling the secondary in, at most, two 
38 
characteristics for any given mutant (5 mutants were strictly primary). Interestingly, 6 of 
the delayed hemolysis mutants were unable to grow on the CAS siderophore media. 
There was one mutant defective for swarming, two defective for swimming, one 
defective for both swimming and swarming, one defective for antibiotic production and 
swimming, one with reduced siderophore activity, one that bound calcofluor, and one that 
bound calcofluor and could not swarm. Lastly, all early hemolysis mutants, with the 
exception of 86 C7, were physiologically identical to the primary parental wild type. 
Since hemolysis mutants were identified based on early or delayed activity, the 
effects of growth rate needed to be considered. Growth assays were performed on all 74 
hemolysis mutants (Data not shown). The majority of mutants exhibited growth rates 
similar to the primary phase parental wild type. For the early hemolysis mutants, 9 out of 
the 11 mutants also had growth rates similar to the parental wild type; however, two early 
hemolysis mutants (86 C7 and 82 HI2) actually displayed growth rates that were slower 
than that of the parental wild type (Figure 5). These results indicate that the altered 






















FIGURE 5. Selected hemolysis mutants were assessed for growth defects via a 24-h growth assay. Representative data points for three 
mutants are shown above. 82 H12 and 86 C7 had slightly decreased growth rates. 69 H6 shows a growth rate comparable to the wild 
type. The other 71 hemolysis mutants displayed similar trends. 
Table 4. Physiological properties of P. temperata mutants altered in hemolvtic activity and their parental wild types 





















































































































































































































































































































































































































































































































































































Table 4 (cont.) 






































































































































































































































Table 4 (cont.) 






































































































































Pigment: Determined by growth on LB agar. Dark pigmented colonies appear orange or yellow in color while light colonies appear 
white or off-white. EMB (Eosin Methylene Blue): Positive (+) dye absorption was indicated by shiny metallic green colonies, while 
negative (-) colonies were pink or purple. MAC (MacConkey): Positive colonies were red colored while negative colonies were pale 
pink or orange (+/- denotes light red colonies less pigmented than the 1° but more than the 2°). NBTA (Nutrient Bromothymol Blue 
Agar): Positive colonies were dark green while negative colonies were light green or pink (+/- denotes green colonies of medium 
shade). Calc (Calcofluor): Positive binding of calcofluor fluoresced under UV light while negative did not fluoresce. Lipase and 
Protease: Positive reactions were indicated by a halo around the colony (>1 mm for lipase, >2 mm for protease), while negative 
reactions lacked a halo (+/- on protease indicates a halo of <2 mm). Antibiotic: The radius of clearing surrounding each colony was 
recorded in mm. CAS (Chrome Azurol S): Positive siderophore production was noted by an orange halo (>2 mm) surrounding the 
colony, while negative production lacked such a halo (+/- indicates a halo <2 mm). Swim and Swarm: The diameters of swim and 
swarm rings were recorded in mm at 48 h incubation. NG (No growth): Repeated culturing attempts yielded no growth of some 
mutants on certain media. All data were recorded at 48 h incubation at 28°C. 
IDENTIFICATION OF PATHOGENESIS MUTANTS 
We were interested in the role that hemolysis activity plays in insect pathogenesis 
and tested this property by the use of an in vitro insect pathogenesis assay. Standardized 
numbers of cells for mutants and parental wild type were injected directly into the 
hemocoel of Galleria mellonella larvae and insect mortality was monitored over time as 
described in the Methods. Figure 6 shows the representative results for the parental wild 
types and select mutants. Virulence was determined by calculating the time required to 
kill 50% of the larval population infected (LT50) and the time required to kill the entire 
population (LTioo). Although the exact times varied by data set, the primary phase 
parental wild type killed half of the infected larvae on average by 47 h (LT50) and the 
entire larval population on average by 55 h (LTioo). Secondary phase parental wild type 
cells were more virulent and had an average LT50 and LTioo of 44 h and 50 h, 
respectively. All of the hemolysis mutants killed the insects; however, none of the 
mutants killed faster than the parental wild type. For the mutants defective in hemolytic 
activity, 15 out of the 44 mutants were also defective in pathogenesis during initial 
screening (Table 5). These mutants showed a delayed pathogenesis response that was 10-
20 h later than the primary phase parental wild type (Figure 6). For the delayed hemolysis 
group, 10 out of the 19 mutants also exhibited a delayed response for pathogenesis. All of 
the 11 early hemolysis exhibited a pathogenesis response similar to the parental wild 
type. These results indicate that hemolysis activity is not required for insect killing, but 
may play a role in the pathogenesis process. The 25 mutants altered in both hemolysis 
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FIGURE 6. The in vitro insect pathogenesis assay identified 25 hemolytic mutants that exhibited a delayed response in pathogenesis. 
The delayed pathogenesis response was characterized by an increase in the LT50 and LTioo by >10 h compared to primary parental 
wild type. Representative data points for two mutants are shown above. The other 20 putative virulence mutants showed similar trends 
(Table 5). 
Table 5. Hemolysis mutants altered in insect pathogenesis as identified by preliminary 
screening. An in vitro insect pathogenesis assay was used to determine LT50 and LTioo as 
described in the Materials and Methods. For these assays, 100 cells were inoculated into 














































































































































Mutant LT50 and LTioo values were standardized to the average LT50 and LTioo of the 
primary parental wild type. Initial pathogenesis testing identified 25 putative virulence 
mutants. Multiplicity of infection (MOI) assays performed with four different infectious 
doses confirmed 10 mutants that remained delayed in pathogenesis by 10 or more h after 
injection with each dose. 
47 
CONFIRMATION OF PATHOGENESIS MUTANTS 
The effect of cell dosage on insect pathogenesis was determined for the 25 
identified hemolysis mutants. Figure 7 shows the results of representative mutants 
compared to the parental wild type. Multiplicity of infection (MOI) was tested by the use 
of variable infectious doses ranging from 10 to 10,000 cells (four doses for each mutant). 
MOI assays showed that 10 out of the 25 hemolysis mutants that displayed reduced 
virulence during the initial screen maintained their delayed virulence. These confirmed 
pathogenesis mutants were 10A Cll , 10A H12, 30 C6, 30 F2, 32 C5, 34 E2, 46 G6, 50 
C5, 53 H3, and 79 B5. Only those mutants that were consistently delayed by 10 h at each 
of the four dosages were counted; mutants that were delayed at some of the doses but not 
all were not considered true pathogenesis mutants. Typically, these mutants would 
exhibit delayed pathogenesis at lower dosages, but as the cellular density increased, the 
mutants had close to wild type pathogenesis, likely due to the accumulation of toxins 
produced. Of the 10 confirmed pathogenesis mutants, seven were defective for hemolysis 
and four had delayed hemolysis (Table 6). 
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FIGURE 7. The effect of cell dosage [multiplicity of infection (MOI)] on insect pathogenesis by the hemolytic mutants. Four MOI 
values of Photorhabdus were injected into 20 G mellonella larvae A) 10,000 cells, B) 1,000 cells, C) 100 cells, and D) 10 cells. 
Representative data points for two mutants are shown above. The other 8 confirmed virulence mutants showed similar trends. 
FURTHER PHENOTYPIC CHARACTERIZATION OF 
CONFIRMED PATHOGENESIS MUTANTS 
The ten confirmed pathogenesis mutants were selected for a more quantitative 
look at physiological characteristics. These mutants were again assayed as previously 
described (Table 4) with the inclusion of DNase activity. Clearing zones and halos for 
lipase, protease, antimicrobial activity, siderophore production, and DNase activity were 
measured in mm (radius), and the diameters of swim and swarm rings were quantified as 
well (mm) (Table 6). Interestingly, all of the ten mutants were altered in at least one 
additional phenotype; no mutants were altered only in hemolysis and pathogenesis. A 
closer look at these ten mutants reveals that two of the defective hemolysis/delayed 
pathogenesis mutants, 10A Cll and 10A HI2, appear identical and may have sibling 
mutations. As mentioned previously, no mutants entirely lack primary characteristics. 
Interestingly, 30 C6, 32 C5, and 34 E2, which are delayed hemolysis/delayed 
pathogenesis, all have increased production of protease and antibiotics compared to the 
primary parental wild type, and are unable to grow on the siderophore medium, again 
indicating possible mutations in the same gene. 46 G6 is impaired in both swimming and 
swarming motility, and mildly defective in protease, DNase, and siderophore production, 
however retains wild type levels of lipase and antibiotic production. 53 H3 is nonmotile, 
has decreased secretion of protease, antibiotics, and siderophore, and does not grow on 
lipase medium. 79 B5 has decreased protease, siderophore, and DNase activity, and is 
defective for swarming. 50 C5 has decreased secretion of all extracellular products, 
except for DNase. 30 F2 has increased antibiotic activity, decreased siderophore activity, 
and is unable to swarm. The wide variations in phenotypes observed even within this 
small group of mutants demonstrate the diversity of genes affecting virulence. 
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Hemolysis activity determined as previously described (Table 3). Pigment: Determined by growth on LB agar. Dark pigmented 
colonies appear orange or yellow in color while light colonies appear white or off-white. Dye binding determined by absorbance of 
dyes on EMB, MAC, and NBTA as previously described (Table 4). Calc (Calcofluor): Positive binding of calcofluor fluoresced under 
UV light while negative did not fluoresce. Extracellular secretion of lipase, protease, antibiotics, and siderophore quantified by 
measuring the radius of zones/halos in mm. DNase: Production of DNase was indicated by a halo around the colony. The radius of 
clearing surrounding each colony was recorded in mm. Swim and swarm: The diameters of swim and swarm rings were recorded in 
mm at 48 h incubation. NG (No growth): Repeated culturing attempts yielded no growth of some mutants on certain media. 
QUANTIFICATION OF PATHOGENESIS MUTANT HEMOLYTIC ACTIVITY 
A liquid hemolysis assay was used to quantify the amount of blood lysing activity 
in the 10 pathogenesis mutants. Samples were measured over a four hour time period and 
hemolytic units were calculated and plotted over time. The hemolytic activity of each 
mutant was compared to the primary parental wild type. Figure 8a shows two 
representative mutants compared to the parental wild types. 79 B5 exhibited a delay in 
the initiation of hemolysis, but once lysing began, the activity followed the same trend as 
the primary. The collective data showed that, although all of the mutants were in some 
way inhibited for hemolysis on blood agar plates, they retained blood lysing activity in 
the liquid assay (Table 7). A few mutants actually showed hemolytic activity earlier than 
the primary. Hemolytic activity was also present in the secondary wild type, which is 
negative for hemolysis on blood agar. The secondary variant had hemolytic activity equal 
to that of the primary; however, the level of hemolysis was decreased in some mutants. 
Each culture was tested for hemolysis using a diluted culture sample, a PBS-
washed cell sample, and a filter-sterilized supernatant sample. Figure 8b compares the 
three sample types for the primary parental wild type. For each culture, wild type and 
mutant alike, the highest hemolytic activity was observed in the diluted culture sample 
(Data not shown). Hemolysis was detected in the washed cell samples, but was greatly 
decreased. None of the samples showed any hemolysis in the supernatant samples. These 
data indicate that the presence of bacterial cells is required for hemolysis, but the activity 
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FIGURE 8. Hemolytic units vs. time in a liquid hemolysis assay. A) Representative data 
points for two mutants are shown above. The other 8 mutants displayed similar trends. B) 
Hemolytic activity was strongest in diluted culture and substantially decreased in PBS-
washed cell samples. Filter-sterilized supernatant lacked hemolytic activity. This was true 
for both primary and secondary parental wild types, as well as the 10 pathogenesis 
mutants. 
53 
Table 7. Hemolytic units of parental wild types and pathogenesis mutants over time in a 


































































50 C5 and 53 H3 were tested separately and have been standardized to the primary 
parental wild type in this data set. All mutants and wild types showed an increase in 
hemolysis over time. 
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MOLECULAR CHARACTERIZATION OF VIRULENCE MUTANTS 
Several of the hemolysis mutants were analyzed at the genetic level to identify 
the site of transposon insertion. 
SOUTHERN HYBRIDIZATION TO CONFIRM SINGLE INSERTIONS 
Southern hybridization was performed to verify that there was only one 
transposon insertion in the genomes of the ten pathogenesis mutants. The transposon is 
designed to insert only once into the genome; however, multiple insertions can occur, 
which could possibly explain the altered effects on both hemolysis and virulence in these 
mutants. A fluorescently-labeled probe designed to bind to the kanamycin gene was used 
to identify the number of insertions in each mutant. Multiple insertions would be visible 
as multiple bands on the blot; however, only one band was seen for each sample. Results 
from Southern hybridization revealed that all ten of the pathogenesis mutants contained a 
single transposon insertion in the genome (Figure 9). 
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FIGURE 9. Southern blotting confirmed single transposon insertions for the pathogenesis 
mutants. One band was detected by the fluorescently-labeled Kan probe for each sample. 
A: pUB394 positive control, B: 10A Cl l , C: 10A H12, D: 30 C6, E: 30 F2, F: 32 C5, G: 
34 E2, H: 46 G6,1: 50 C5, J: 53 H3, K: 79 B5, L: primary wild type negative control. 
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IDENTIFICATION OF TRANSPOSON INSERTION SITES 
Rescue cloning was used to identify the specific site of the transposon insertion. 
The transposon and flanking gene region was recovered via rescue cloning and plasmid 
sequencing. Sequencing of the rescued plasmid determined the genes disrupted by the 
transposon (Tn5). The sequenced plasmids were compared to the P. temperata NCI9 
genome, providing a good database for site identification. The availability of the P. 
luminescens subsp. laumondii TT01 and P. asymbiotica subsp. asymbiotica ATCC 43949 
genomes also provided a good baseline for comparison. The insert site for 16 mutants 
displaying different hemolytic and pathogenic phenotypes were identified (Table 8). 
Interestingly, although the P. temperata genome contains at least 24 hemolysis genes, 
none of the 16 characterized mutants had the transposon inserted into genes directly 
involved in hemolysis. Instead, the observed phenotypic defects were due to disruptions 
in genes mainly involved in outer membrane proteins, export systems, and RNA 
degradation. A few mutants had disruptions in other types of genetic elements, including 
a transposase and a phage repressor protein. Of particular interest, however, were those 
mutants confirmed to have alterations in both hemolysis and virulence. 
Genes for eight pathogenesis mutants were identified: 10A Cll , 10A HI2, 30 
C6, 30 F2, 46 G6, 50 C5, 53 H3, and 79 B5. Mutants 10A Cll , 10A H12, and 79 B5 had 
disruptions in genes involved in RNA degradation. 10A Cll and 10A H12 mapped to a 
gene encoding Exoribonuclease II, a gene previously identified in a mutant altered in 
motility and pathogenesis (Rowedder, 2009). 79 B5 mapped to a gene encoding an 
adenosine (5')-pentaphospho-(5")-adenosine pyrophosphohydrolase, which belongs to the 
nudix superfamily of RNases. Additional pathogenesis mutants identified several 
hypothetical proteins (30 F2 and 50 C5), an LPS heptosyltransferase I (53 H3), a 
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carbamoyl-phosphate synthase large subunit (30 C6), and a transposase (46 G6). 46 G6 
mapped to a transposase with seven identical paralogs in the genome. Additional 
sequencing with forward primer M13F determined that the transposon had been inserted 
in pte4664, the transposase located on contig 9, which is adjacent to a secreted protein 
Hep (hemolysin co-regulated protein), part of the Type VI secretion system. 
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Table 8. Transposon insertion sites for mutants of interest 
Mutant 
Identity 

















E = 0.0 
934/936 (99%) 
E = 0.0 
773/773 (100%) 
E = 0.0 
420/420(100%) 
E = 0.0 
943/944 (99%) 
E = 0.0 
942/943 (99%) 
E = 0.0 
919/928 (99%) 
E = 0.0 
911/919(99%) 
E = 0.0 
942/944 (99%) 
E = 0.0 
518/518(100%) 
E = 0.0 
945/945 (100%) 
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Table 8 (cont.) 
Mutant 
Identity 
(%) E value Gene 
Plu or Pau 















E = 0.0 
777/778 (99%) 
E = 0.0 
935/935 (100%) 
E = 0.0 
677/677 (100%) 
E = 0.0 
932/934 (99%) 



















synthase large chain 
Carbamoyl-phosphate 
synthase large chain 
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Identity (%) E value: Determines percentage of sequenced nucleotides with exact matches in the genome for the identified gene. Gene: 
pte number identifies sequence location in P. temperata genome. Plu or Pau homologue: plu and pau numbers identify location of 
matching gene in P. luminescens and P. asymbiotica genomes, respectively. Insert Site: Identifies the location of transposon insertion 
within the gene. Gene function: Putative product produced by the identified gene, based on sequence similarities with other closely 
related genomes. 
CONFIRMATION OF TRANSPOSON INSERTION SITES BY PCR 
To confirm the location of the transposon insertion identified by rescue cloning, 
two PCR approaches were used. Initially, primers (Table 2) were used to amplify the 
genes of interest from genomic DNA. Product sizes were compared to products amplified 
from the primary parental wild type genomic DNA. The presence of the transposon 
within a particular gene results in a product size approximately 2.5 kb larger than the 
expected product size. This size discrepancy allowed us to determine which gene housed 
the transposon in one particular mutant of interest, 79 B5, where sequencing had 
indicated a possible overlap of two genes by the transposon. 
Sequencing of the rescued plasmid from 79 B5 identified a transposon insertion 
site 147 bases into pte3S0S, a gene encoding a nudix protein involved in RNA 
degradation. Immediately adjacent to this gene is pte3807, a nitrogen regulation-
associated phosphocarrier protein kinase/phosphorylase. The expected product size for 
amplification of pte380S from genomic DNA with the RT-PCR primers (Table 2) is 370 
bp, as observed in the 1° WT sample (Figure 10a); however, amplification of pte3S0S 
from mutant 79 B5 yielded a product greater than 3.0 kb, confirming the presence of the 
transposon within this gene. The expected product size of amplified pte3&07 is 
approximately 0.7 kb, which was observed in both the 1° WT and 79 B5 samples, 
indicating that the transposon does not overlap pte3807. 
In addition to amplifying the genes from genomic DNA to verify transposon 
location, RT-PCR was used to determine any potential downstream effects of insertion 
for mutants of interest. End-point RT-PCR can determine whether a gene is expressed 
and transcript is made, or whether the insertion of the transposon has impeded gene 
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expression. Mutant 79 B5 was analyzed for transcription of bothjo/e3808, the location of 
transposon insertion, andpte3807, the adjacent downstream gene. For both the 1° and 2° 
parental wild types, ample transcript of both pte380S and/?te3807 was present (Figure 
10b). 79 B5 lacked transcript for pte3808, indicating that transposon insertion had 
knocked out all expression of this gene. 79 B5 did, however, retain expression of 
pte3807, demonstrating that the interruption in pte3808 did not have an effect on the 
expression of downstream genes. This confirmation indicates that pte3808 is not located 
within an operon, and that 79 B5 is a candidate for genetic complementation. 
End point RT-PCR was also performed on 46 G6, the mutant with the 
transposase adjacent to the Hep locus. Since Hep is putatively involved in hemolysin 
activity, we wanted to see if the transposon insertion had downstream effects on this 
gene, causing the observed phenotypes. RT-PCR on Hep with HCP Set 5 primers (Table 
2) showed that transcript was actually being made for this gene (Data not shown). This 
result indicates that the transposon insertion in/?te4664, the transposase, did not have 





FIGURE 10. Confirmation of transposon insertion sites via PCR. a) PCR of genomic DNA yielded products of different sizes, 
confirming transposon location. A: 2-Log DNA Ladder, B: 1° WTpte3808, C: 79 B5;?te3808, D: 1° WT/?te3807, E: 79 B5pte3807, 
F: 1° WT>te3808 F with/tfe3807 R, G: empty, H: 79 B5 pte3808 F withpte3807 R, I: 2-Log DNA Ladder, J: pte3808 no template 
control, K: pte3807 no template control, L: pte3808 F with/?fe3807 R no template control, b) End-point RT-PCR confirmed there 
were no downstream effects of transposon insertion. A: 2-Log DNA Ladder, B: 1° WT pte3808 transcript, C: 2° WT pte3808 
transcript, D: 79 B5pte3808 transcript, E: empty, F:pte3808 transcript no template control, G: empty, H: 1° WTpte3807 transcript, I: 
2°pte3807 transcript, J: 79 B5pte3807 transcript, K: empty, L: pte3807 transcript no template control. 
CHAPTER TV 
DISCUSSION 
IDENTIFICATION OF MUTANTS ALTERED IN HEMOLYSIS AND PATHOGENESIS 
Previous research conducted on the pathogenesis of Photorhabdus has begun to 
elucidate the virulence mechanisms employed by this organism. However, despite 
advancements in our understanding of the physiology of Photorhabdus, little knowledge 
exists on the precise function and mechanisms of the hemolysins in this system. The 
goals of this study were to investigate the hemolytic activity of Photorhabdus and to 
identify the relationship between hemolysis and pathogenesis. To accomplish these goals, 
a series of screening procedures were employed. Initially, a previously constructed 
10,000-transposant library containing primary phase mutant P. temperata was screened 
for altered hemolytic activity using a sheep blood agar plate assay. For this screening 
procedure, time to initiation of hemolysis was used as the criterion for discerning mutants 
from the wild type. The screen was conducted this way because the plate assay is a 
qualitative assessment of hemolysis; increased or decreased levels of activity are not 
identifiable with this method. For a quantitative analysis of hemolytic activity, a liquid 
hemolysis assay is necessary. This quantitative assay is significantly more labor intensive 
than the plate method, rendering the screening of this volume of mutants unfeasible. The 
liquid assay is more suitable for analyzing a smaller subset of mutants, such as the 10 
pathogenesis mutants identified in this study. 
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The object of screening the library was to identify mutants that were altered in the 
synthesis, regulation, or secretion of hemolysins; therefore, identified hemolysis mutants 
were categorized into one of three groups: Defective, Delayed, and Early. By using these 
classifications, I expected to find some representative types of mutations. I expected that 
the defective hemolysis mutants, in which hemolytic activity had been completely lost, 
would contain disruptions in genes related to hemolysin synthesis. Delayed and early 
hemolysis mutants would therefore likely represent mutants with disruptions in transport 
mechanisms and regulators or suppressors of hemolysis activity. In reality, I identified 
mainly genes involved in regulation and transport, but none directly related to hemolysis. 
Although labor-intensive, screening the library in this way offers several distinct 
advantages over site-directed mutagenesis for the investigation of hemolysis. The P. 
temperata genome contains at least 24 genes putatively involved in hemolysis. Direct 
knock-outs of these genes may be useful for understanding the role of each specific gene 
in hemolysis, but would not identify additional regulatory elements indirectly involved in 
hemolysis expression. 
A second advantage of screening the library directly is that it generates a smaller 
pool of mutants that can be tested for pathogenesis. The in vitro pathogenesis assay used 
in this study is another labor-intensive process; testing the entire transposant library for 
mutants altered in pathogenesis is not feasible. Therefore, smaller groups of mutants are 
characterized for virulence. Previously, 86 identified motility mutants were tested for 
pathogenesis (Michaels, 2006; Rowedder, 2009), and in this study, 74 hemolysis mutants 
were tested. Although site-directed mutagenesis of hemolysis genes would also create a 
mutant pool for testing, screening the entire library identifies a larger group of mutants 
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with a broader range of mutations, thus providing more opportunities to identify genes 
involved in pathogenesis. 
The P. temperata genome is approximately 5 Mb in length, encoding roughly 
5,000 genes. When the transposon library was constructed, it was designed to give 2x 
coverage of the genome, hence the 10,000 primary-phase mutants. Theoretically, every 
gene in the genome should then be represented by two mutants. Given that P. temperata 
has 24 putative hemolysin genes, I expected to find approximately 48 mutants with 
disruptions in hemolysis genes. I also expected to find a number of pleiotropic mutants 
with disruptions in global regulators and other indirectly-related genes. However, the 
insertion of the transposon appears to be biased. This means that the Tn5 has a tendency 
to recognize hot spots in the genome, resulting in many mutants having insertions in the 
same gene. I observed this in my study as well; I identified four groups of mutants with 
insertions in the same genes. None of the 16 mutants for which I identified the site of 
transposon insertion had disruptions in hemolysis genes. I believe this is due to bias in 
choosing which mutants to characterize on the genetic level. Although I did find 34 
mutants that were altered only in hemolysis, the mutants altered in both hemolysis and 
pathogenesis were of primary interest in this study, followed by hemolysis mutants that 
displayed other pleiotropic effects. Choosing these mutants to characterize probably 
decreased my chances of identifying genes directly related to hemolysis, as those mutants 
most likely were only affected in hemolysis expression. 
The methods used in this study were designed to provide a broader understanding 
of the genetics involved in the hemolysis and pathogenesis of Photorhabdus. The genes 
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and their pleiotropic effects identified in this study contribute new data to the growing 
insight into the physiological mechanisms of Photorhabdus. 
MULTIPLE HEMOLYSINS ARE ACTIVE IN PHOTORHABDUS 
Although all of the pathogenesis mutants were either defective or delayed for 
hemolysis on blood agar plates, I expected that these mutants would retain some 
hemolytic activity in a liquid assay. Data mining in the RAST and IMG (integrated 
Microbial Genomes; http://img.jgi.doe.gov/) databases identifies 24 putative hemolysin 
genes in the P. temperata genome, 25 in the P. luminescens genome, and 18 in the P. 
asymbiotica genome. These numbers indicate that Photorhabdus most likely contains a 
variety of different hemolysins and genes involved in the regulation of hemolysis. 
Moreover, Xenorhabdus has been shown to contain multiple hemolysins which are 
independently regulated and active at different stages of stationary phase (Brillard et al., 
2001). The findings from the liquid assay showed that the 10 pathogenesis mutants did 
have some hemolytic activity when in liquid culture. These data support the notion that 
Photorhabdus encodes multiple types of hemolysin, or has paralogs encoding the same 
hemolysins. This result was expected given the number of putative genes involved in 
hemolysin expression. This is also consistent with a study by Brillard et al. (2002), which 
showed evidence of at least two hemolysins in Photorhabdus, and demonstrated that 
PhlA activity was only detected using a liquid assay. It is likely that some hemolysins 
may require close cellular contact with the blood cells in order to induce lysis. This may 
explain why hemolysis was not visible on blood agar, but was detected in liquid culture 
where the bacterial cells are able to constantly mix with the blood cells. 
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Another interesting finding from this assay was that the secondary wild type had 
hemolytic activity that was equal to, if not slightly higher than, the primary wild type. 
This finding further supports the idea that different hemolysins are active via different 
mechanisms. Furthermore, the hemolysins producing annular ring formation on the plate 
assay are not the same as those active in liquid culture. This notion is consistent with 
previous findings of hemolytic activity in the secondary phase (Brillard et al., 2002). 
HEMOLYTIC ACTIVITY IN PHOTORHABDUS IS CELL-ASSOCIATED 
In 2001, Brillard et al. showed that active hemolysin was secreted from 
Xenorhabdus into the extracellular medium, and that the culture supernatant retained 
hemolytic activity. In contrast, Photorhabdus culture was not shown to have a secreted 
hemolytic compound (Brillard et al., 2001; Brillard et al., 2002). To test this study, I 
performed a liquid hemolysis assay using three sample types for each culture. My 
findings confirm the findings of Brillard et al.; bacterial cells must be present in the 
sample for hemolysis to occur. Furthermore, the highest hemolytic activity is achieved 
when cells and culture medium are used together. What this may indicate is that the 
hemolysins secreted by Photorhabdus probably become inactive fairly quickly. The 
hemolysins in the filter-sterilized supernatant must completely degrade before the assay 
is complete. In contrast, the PBS-washed cells continue to secrete hemolysin during the 
assay, but the overall concentration is less than in the original culture medium containing 
bacterial cells. Additionally, the presence of a cell-associated co-factor may be required 
for the activity of secreted hemolysins. This may explain why the cells plus culture 
sample appears to have a synergistic hemolytic effect compared to the cell-only sample. 
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HEMOLYSIS MAY NOT BE REQUIRED FOR FULL VIRULENCE 
My initial hypothesis was that the hemolytic activity observed in Photorhabdus 
assisted the bacteria during insect infectivity. Several studies on Xenorhabdus indicate a 
possible role of hemolysins in immunoevasion (Brillard et al., 2001; Cowles and 
Goodrich-Blair, 2005). However, the data from this study imply this may not be the case 
for Photorhabdus. Most of the hemolysis mutants were not altered in virulence; in fact, 
only 10 of the 74 hemolysis mutants were confirmed to have delayed pathogenesis. This 
finding indicates that hemolysis does not play a significant role in pathogenesis. The few 
mutants that were altered in both hemolysis and pathogenesis are most likely the result of 
disruptions in global regulatory elements, rather than a correlation between hemolytic 
activity and virulence. This notion is supported by the genes that were identified for 
several mutants, described in the following sections. 
REGULATION OF HEMOLYSIS AND VIRULENCE IN PHOTORHABDUS 
As previously stated, the majority of the genes identified in this study were 
regulatory or transport-related. The lipopolysaccharide heptosyltransferase I protein, 
identified in defective hemolysis/delayed virulence mutant 53 H3, is responsible for 
attaching the first heptose molecule to Kdo during LPS inner-core synthesis (Grizot et al., 
2006). Interestingly, the absence of this heptose is known to cause attenuated virulence in 
Gram negative bacteria. This coincides with my finding of delayed pathogenesis for this 
mutant. Incomplete formation of LPS likely also inhibits the adequate secretion of 
hemolysin, thus resulting in the defective hemolysis of this mutant. Another translocating 
protein, phosphoserine aminotransferase (PSAT), was identified in early hemolysis 
mutant 86 C7. PSAT catalyzes the second step of the phosphorylated serine biosynthesis 
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pathway (Mishra et al., 2010). This enzyme has also been shown to be involved in 
alanine synthesis (Kim et al., 2010). 86 C7 is affected in almost every phenotype, 
including a decrease in growth rate, which is not surprising given the likely auxotrophy 
of this mutant. The disruption in the synthesis of these amino acids likely affects many 
other intermediates and pathways involved in homeostasis. 
The delayed hemolysis/delayed pathogenesis mutant 30 F2 identified a transposon 
insertion site within a gene encoding a hypothetical protein of unknown function. 
However, this gene is immediately upstream of the gene encoding UDP-glucose 4-
epimerase, the enzyme that catalyzes the stereochemical conversion of UDP-glucose to 
UDP-galactose (Mori et al., 2008). Many virulence factors are synthesized using UDP-
galactose, therefore it would makes sense that this mutant has a delay in pathogenesis if 
the transposon is affecting transcription of this downstream gene. This is a likely 
explanation, but QRT-PCR would be needed to determine to what extent the transposon 
is affecting this gene, if at all. 
The defective hemolysis mutant 41 B3 had a disruption in the ATP-dependent 
protease HslV. HslV is a heat shock protein that functions as the proteolytic subunit of 
the two-component ATP-dependent protease HslVU (Lee et al., 2009). This complex is 
important in regulatory protein turnover; in this way, inactivation of HslV is probably 
inhibiting the turnover of hemolysin repressor proteins. Without the inhibition of these 
repressors, hemolysin activity would continue to be suppressed. 
The last two unique mutants, 46 G6 and 71 H4, had transposon insertions in genes 
that cannot be clearly related to the observed phenotypes. 46 G6 identified a transposase 
sequence; this transposase actually has seven identical paralogs in the P. temperata 
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genome. Sequencing from the opposite end of the transposon was able to determine 
which paralog actually contained the insertion. This transposase is located next to the 
secreted protein Hep (hemolysin coregulated protein), which is part of the Type VI 
secretion system. However, end point RT-PCR determined that this Hep gene was still 
producing transcript, which discredits the possibility that the observed phenotypes were 
due to disruptions with Hep expression. The disruption in 71 H4 is equally puzzling; this 
gene has similarities with the lambda phage repressor protein CI, which is involved in the 
switch between the lysogenic and lytic growth phases (Galkin et al., 2009). This repressor 
self-cleaves under the SOS response. The most likely explanation is that the proteins 
coded by these two genes act as regulators to biological intermediates of other pathways 
that are indirectly related to the expression of hemolysis and virulence. 
MEMBRANE FUSION PROTEIN PRTC IS INVOLVED IN HEMOLYSIS 
Two defective hemolysis mutants, 22 A2 and 90 E2, had insertions within the same 
gene, prtC. The insertion sites for these mutants are located 1110 bp apart; therefore, 
these mutants are not siblings but rather arose independently from one another. 
Phenotypically, these mutants are indistinguishable; both express primary wild type 
characteristics with the exception of protease secretion, for which they are defective. This 
observation is not surprising given that prtC belongs to the prtBCD protease ABC 
transporter locus (Bowen et al., 2003). PrtC is a membrane-fusion protein (MFP) and is 
involved in the secretion of the RTX-like metalloprotease PrtA. Although once suspected 
to be a major virulence factor in Photorhabdus, PrtA actually is involved in the 
bioconversion of host tissues during late infection. For this reason it is not surprising that 
22 A2 and 90 E2 retained wild type virulence while losing protease activity. 
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Interestingly, NCBI's BLAST program identified sequence similarities with a gene 
encoding HlyD in Serratia odorifera. HlyD is a type I secretion membrane fusion protein 
involved in the extracellular transport of hemolysin (Pimenta et al., 2005). In E. coli, this 
protein spans the periplasm and is responsible for the direct extracellular transport of 
Hemolysin A (HlyA). Members of the MFP family share structural domain similarities 
and transport a variety of compounds out of the cell. This suggests the possibility that the 
PrtC protein of Photorhabdus may share involvement in the transport of hemolysin. 
Disruption of prtC may have caused an absence of expression or a structural misfolding 
of the protein, which would inhibit the exportation of protease and possibly hemolysin as 
well. 
DISCREPANCIES IN PLEIOTROPIC EFFECTS OF IDENTICAL MUTANTS 50 C5 AND 51F9 
Sequencing of two defective hemolysis mutants, 50 C5 and 51 F9, identified 
transposon insertion sites at the same positions within pte2343, a gene encoding a 
conserved hypothetical protein. Phenotypic characterization revealed that these two 
mutants are physiologically identical, exhibiting primary phase wild type characteristics; 
however, 50 C5 is a confirmed pathogenesis mutant, while 51 F9 is not. Initial virulence 
screening of 51 F9 identified an LT50 and LTioo of >57 h and >65 h, respectively. Both 
times were delayed by 10 h when compared to the primary parental wild type. However, 
the MOI assay did not confirm this delay in pathogenesis at the four cell dosages tested. 
Genetically, these two mutants are identical; therefore, all phenotypes should be identical 
as well. There are a few possible explanations as to why only one of these mutants 
consistently exhibits delayed pathogenesis. 
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One such explanation for this discrepancy in virulence may be attributable to the 
complexity of using a live multicellular organism. Although the in vitro killing assay 
using Galleria mellonella is an effective means of testing virulence levels (Waterfield et 
al., 2009), it can also be quite variable due to a number of factors. Some of the difficulties 
associated with using a live multicellular model are the extreme sensitivity of the larvae 
to hot and cold temperatures. Also, larval age, feed, conditions during shipment, as well 
as the overall health of a particular batch of larvae upon arrival all contribute to 
variability in the testing process. The use of controls helps to ameliorate some of these 
fluctuations, but inconsistencies between data sets are still possible. The MOI assay for 
50 C5 may have been tested on a slightly stronger batch of larvae, resulting in a more 
noticeable delay in pathogenesis compared to 51 F9. Testing these two mutants within the 
same batch of larvae may resolve this discrepancy. 
Another possible explanation for the discrepancy could be that 51 F9 may have a 
double insertion. Southern analysis was only performed on 50 C5, which showed that this 
mutant contains only one transposon insertion. 51 F9 has not been analyzed by Southern 
blot, so a possibility remains that this mutant may have multiple transposon insertions. 
This option could explain the pathogenic incongruity between these two seemingly 
identical mutants. Southern analysis would need to be performed to rule out this 
possibility. 
REGULATORY EFFECTS OF THE CARBAMOYL-PHOSPHATE SYNTHASE LARGE CHAIN 
A second group of hemolysis mutants had transposon insertion sites within the same 
gene. 30 C6, 32 E4, and 41 D5 were all delayed for hemolysis and had disruptions in 
carB, the gene encoding the large subunit of the carbamoyl-phosphate synthetase (CPS) 
73 
holoenzyme. CPS is a heterodimer involved in pyrimidine biosynthesis (Lund et al., 
2010). The large subunit specifically catalyzes carbamoyl phosphate formation, while the 
small subunit hydrolyzes glutamine. Carbamoyl phosphate subsequently functions in 
arginine and pyrimidine nucleotide synthesis (Holden et al., 1999). 
30 C6, 32 E4, and 41 D5 display primary wild type characteristics with the 
exception of siderophore production. These three mutants were unable to grow on CAS 
agar. This is not surprising given that CAS is a minimal-nutrient medium. Interference 
with pyrimidine synthesis could easily hinder the production of arginine or other organic 
compounds required for growth. The resulting auxotrophy would explain why these 
mutants do not grow on CAS. 
Although a definitive role of CPS in hemolysin expression is not immediately 
clear, it is likely that this disruption causes an incomplete product formation that is in 
some way involved in the regulation of hemolysis. For instance, irregular protein folding 
or the absence of a crucial regulatory intermediate could explain the delay in hemolysis 
initiation. If a particular repressor for hemolysis was malformed in its inducer binding 
site, then the repressor would continue to interfere with hemolysin expression. Another 
possibility could be the absence of an activator required to initiate hemolysin expression. 
Both of these scenarios would cause a lack of hemolysis until the activity of additional 
hemolysins, under other forms of regulatory control, were able to compensate for the 
inactive hemolysin. This could explain why hemolysis is not observed until at least 48 h 
growth. 
One other peculiar observation surrounds these CPS mutants, and that is that 30 
C6 is also delayed for pathogenesis, while 32 E4 and 41 D5 are not. 32 E4 and 41 D5 
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were both putative pathogenesis mutants during initial screening, but were not confirmed 
at the four dosages injected during the MOI assays. As explained before with 50 C5 and 
51 F9, it is possible that variability in insect health during testing biased the confirmation 
of only 30 C6 as delayed pathogenesis. However, unlike 50 C5 and 51 F9, these three 
mutants all have different insertion sites. The insertion site of 30 C6 is the closest to the 
beginning of the gene; therefore, it is possible that 32 E4 and 41 D5 have enough 
sequence transcribed to translate into a partially functional protein, whereas the gene 
function in 30 C6 could be entirely knocked out. 
10A Cll AND 10A H12 ARE IDENTICAL EXORIBONUCLEASE II MUTANTS 
Molecular analysis of the pathogenesis mutants 10A Cll and 10A H12 revealed 
mutations in the rnb gene which encodes Exoribonuclease II (RNase II). These two 
mutants are identical; the transposon insertion site within the disrupted gene is the same 
in both mutants. This finding indicates that these two mutants arose from a single 
transformed cell; therefore, 10A Cll and 10A H12 are indistinguishable, both genetically 
and phenotypically. Interestingly, the RNase II gene found in this mutant pair was also 
found previously in a pathogenesis mutant, UNH 1307 (Rowedder, 2009). Similar to 
UNH 1307, 10A Cll and 10A H12 are completely defective for motility, hemolysis, and 
dye binding on MacConkey and EMB. 10A Cll and 10A H12 are also negative for 
lipase, although UNH 1307 was not tested. These three mutants are not identical, 
however. UNH 1307 is completely defective for protease, antimicrobial activity, and 
calcofluor binding. 10A Cll and 10A HI2 bind calcofluor, and are positive, albeit 
significantly reduced (<1 mm), for protease and antimicrobial activity. Although the 
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precise insertion site of UNH 1307 is unknown, it can be speculated that this mutant is not 
an identical clone of the other two. 
RNase II is a 3' to 5' exoribonuclease and is a key player in RNA maturation and 
turnover, as well as mRNA decay (Zuo et al., 2006; Domingues et al., 2009). The 
structure of RNase II is comprised of two cold shock domains, one catalytic domain, and 
one substrate-binding domain (Zuo et al., 2006; Arraiano et al., 2010). This complex 
hydrolyzes single-stranded RNA by excising mononucleotides from the 3' end, leaving a 
short oligonucleotide. Enzyme expression and activity is controlled at both the 
transcriptional and post-transcriptional levels (Domingues et al., 2009) and is also 
dependent on environmental conditions. For this reason, RNase II may be involved in the 
stress response of pathogens during infection. 
79 B5 IS AN RNA PYROPHOSPHOHYDROLASE (RPPH) MUTANT 
Molecular analysis of 79 B5, a defective hemolysis/delayed pathogenesis mutant, 
identified a disruption in nudH, a gene encoding adenosine (5')-pentaphospho-(5")-
adenosine pyrophosphohydrolase. This protein is actually an RNA pyrophosphohydrolase 
(RppH), which is a member of the Nudix hydrolase superfamily. Proteins belonging to 
the Nudix family have a wide range of functions but are all characterized by their ability 
to hydrolyze substrates containing a nucleoside diphosphate attached to a functional 
group, X (McLennan, 2006). The general purpose of these proteins is cellular 
housecleaning and homeostasis by degrading extraneous metabolites and biochemical 
intermediates. RppH is one particular Nudix protein involved in the initiation of mRNA 
degradation. RppH cleaves the 5' end of triphosphorylated mRNA to generate a 
monophosphorylated RNA which in turn is more susceptible to the endonucleolytic 
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activity of RNase E (Deana et al., 2008). In this way, RppH is thought to be involved in 
initiating the rapid turnover of transcript in prokaryotes. 
MULTIPLE RNASES MAY BE INVOLVED IN THE REGULATION OF PATHOGENESIS 
Genetic analysis of mutants altered in pathogenesis identified two different 
RNases in Photorhabdus: RNase II and RppH. Although the RNase II mutants (10A CI 1, 
10A HI2, and UNH 1307) and the RppH mutant (79 B5) are not phenotypically identical 
to one another, it is likely that the cause of the absence of hemolysis and delay in 
pathogenesis are the same. 
RNase II degrades mRNA by hydrolyzing nucleotides from the 3' end of ssRNA. 
RppH cleaves phosphates from the 5' end of triphosphorylated mRNA, thus marking the 
message for subsequent degradation by RNase E. Although these mechanisms are slightly 
different, the end result is the same: mRNA decay. It is likely that, in both cases, the 
mRNA being degraded encodes repressors of global regulators that ultimately control the 
expression of hemolysis and virulence factors. If the activity of either RNase II or RppH 
is knocked out, then the message from which these repressors are translated will not be 
degraded. This would result in overexpression of the repressors; the global regulators 
would continue to be suppressed. This suppression could inhibit the production of 
hemolysins and critical virulence factors, in addition to any other genes under the control 
of that regulator. 
Traditionally, RNA was believed to function only as transcript or to carry out 
translation. We are just now beginning to fully understand the importance of RNases and 
non-coding RNAs in the genetic regulation of prokaryotes. Transcriptional activation and 
repression can be controlled by non-coding RNA, especially under conditions of stress 
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(Boots and Moll, 2009). Recent studies also show a definite role of RNases in 
pathogenesis. Non-coding RNAs have also been shown to regulate the RNA chaperone 
Hfq, which is involved in virulence (Boots and Moll, 2009). Erova et al. (2008) showed 
that the exoribonuclease RNase R is a cold shock protein involved in the pathogenesis of 
Aeromonas hydrophila. Complementation confirmed that RNase R is encoded by the 
virulence-associated gene vacB. Complementation of UNH1307 also showed a 
restoration of wild type virulence (Rowedder, 2009). To verify the role of RNase II and 
RppH in causing the observed hemolysis and pathogenesis phenotypes in my mutants, 
complementation will need to be performed. 
SIGNIFICANCE 
During this study I screened the 10,000-transposant library for hemolysis and 
identified 74 displaying defective, delayed, or early hemolysis. Subsequent pathogenesis 
testing confirmed that 10 of these mutants are also delayed for pathogenesis. This finding 
does not provide evidence for the direct involvement of hemolysins in insect infectivity 
by Photorhabdus; however, these mutants do provide novel insight into the genes 
involved in the regulation of both hemolysis and virulence. Genetic characterization of 16 
mutants identified a diverse array of regulatory and transport proteins that are involved in 
the control of hemolysis, and in some cases virulence, in Photorhabdus. One of the most 
important findings from this study is the further support for the regulatory role of RNases 
and non-coding RNAs in Photorhabdus. 
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FUTURE DIRECTIONS 
The primary focus of this study was to investigate the potential relationship between 
hemolysis and virulence. This aim was achieved mainly by looking at mutants defective 
in both characteristics, which excluded the 11 identified early hemolysis mutants. These 
mutants, however, display some unique characteristics that are worth looking into. 
Interestingly, although the 11 early hemolysis mutants initiate hemolysis before the 
primary, these mutants do not appear to have an increased level of hemolytic activity. 
Although the plate assay method is not quantitative, the early mutants all had zones of 
hemolysis that were several mm smaller than the primary parental wild type, despite 
showing early signs of hemolysis. A liquid assay is necessary to confirm the potential 
decreased level of hemolysis. This group of mutants could be a very interesting collection 
to study for mechanisms of transport and regulation, as there appears to be an inverse 
relationship between the time of hemolysis initiation and the overall level of blood lysing 
activity. Additionally, a more in depth look at the virulence of these mutants may reveal 
interesting data. Preliminary screening of hemolysis mutants for pathogenesis defects was 
primarily focused on the identification of mutants with decreased virulence. Initial 
screening of the early hemolysis mutants did not identify mutants with enhanced 
virulence, but a closer look at this group may reveal mutants with enhanced pathogenesis 
that were previously missed given the focus of this study. An in-depth characterization of 
this group of mutants would be an interesting and advisable project for an undergraduate. 
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